• PDR Search

    Required field
  • Advertisement
  • FDA Date: 06/27/2017

    Revlimid (lenalidomide) REMS

    Goals of the Revlimid (lenalidomide) REMS Program

    The goals of the REVLIMID risk evaluation and mitigation strategy are as follows:

    1. To prevent the risk of embryo-fetal exposure to REVLIMID.

    2. To inform prescribers, patients, and pharmacists on the serious risks and safe-use conditions for REVLIMID.

    REMS Elements

    • Elements to Assure Safe Use

    • Implementation System